<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Function reference â€¢ drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Function reference"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a>
    <a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a>
    <div class="dropdown-divider"></div>
    <a class="dropdown-item" href="../articles/index.html">More articles...</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-index">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Function reference</h1>
    </div>

    <div class="section level2">
      <h2 id="basic-setting">Basic setting<a class="anchor" aria-label="anchor" href="#basic-setting"></a></h2>
      
      <p class="section-desc"></p><p>Optimally plan basic phase II/III drug development programs.</p>

      
    </div><div id="" class="section level2">
      
      
      

      <dl><dt>
          
          <code><a href="optimal_tte.html">optimal_tte()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning with time-to-event endpoint</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_binary.html">optimal_binary()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning with binary endpoint</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_normal.html">optimal_normal()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning with normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="bias-adjustment">Bias adjustment<a class="anchor" aria-label="anchor" href="#bias-adjustment"></a></h2>
      
      <p class="section-desc"></p><p>As phase III is only conducted in case of promising phase II results, treatment effect estimates from phase II generally overestimate the treatment effect. The following methods supply bias adjustment strategies for optimal program planning.</p>

      
    </div><div id="" class="section level2">
      
      
      

      <dl><dt>
          
          <code><a href="optimal_bias.html">optimal_bias()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for time-to-event endpoints
when discounting phase II results</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_bias_binary.html">optimal_bias_binary()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning when discounting phase II results with binary endpoint</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_bias_normal.html">optimal_bias_normal()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning when discounting phase II results with normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="multi-trial-programs">Multi-trial programs<a class="anchor" aria-label="anchor" href="#multi-trial-programs"></a></h2>
      
      <p class="section-desc"></p><p>More and more often, regulatory authorities require more than one confirmatory phase III study to have delivered a significant result. With the following methods, the planning of multi-trial programs can be optimized.</p>

      
    </div><div id="" class="section level2">
      
      
      

      <dl><dt>
          
          <code><a href="optimal_multitrial.html">optimal_multitrial()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed for time-to-event endpoints</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_multitrial_binary.html">optimal_multitrial_binary()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_multitrial_normal.html">optimal_multitrial_normal()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed</dd>
      </dl></div><div class="section level2">
      <h2 id="multi-arm-trials">Multi-arm trials<a class="anchor" aria-label="anchor" href="#multi-arm-trials"></a></h2>
      
      <p class="section-desc"></p><p>An efficient way of discovering effective treatments among a range of treatment choices is the conduct of multi-arm trials, which can be optimally planned using the following methods.</p>

      
    </div><div id="" class="section level2">
      
      
      

      <dl><dt>
          
          <code><a href="optimal_multiarm.html">optimal_multiarm()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with
time-to-event endpoint</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_multiarm_binary.html">optimal_multiarm_binary()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with
binary endpoint</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_multiarm_normal.html">optimal_multiarm_normal()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with
normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="multiple-endpoints">Multiple endpoints<a class="anchor" aria-label="anchor" href="#multiple-endpoints"></a></h2>
      
      <p class="section-desc"></p><p>In some trials, multiple endpoints may be of interest. Drug development programs with multiple endpoints can be optimized using the following methods.</p>

      
    </div><div id="" class="section level2">
      
      
      

      <dl><dt>
          
          <code><a href="optimal_multiple_tte.html">optimal_multiple_tte()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for programs with multiple
time-to-event endpoints</dd>
      </dl><dl><dt>
          
          <code><a href="optimal_multiple_normal.html">optimal_multiple_normal()</a></code> 
        </dt>
        <dd>Optimal phase II/III drug development planning for programs with multiple
normally distributed endpoints</dd>
      </dl></div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Stella Erdmann, Johannes Cepicka, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

